Demonstrates accurate detection of glycocholic acid, suggesting a new tool for HCC screening.
. Moreover, the developed 2D-PCH displayed excellent specificity, good reversibility and satisfactory recovery ranging from 93.02% to 106.07% towards spiked samples. Therefore, the developed 2D-PCH-based immunoassay provided a visual, label-free, convenient, quantitative and reusable POCT method for the biomarker GCA, with great potential for future HCC clinical screening applications.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: